Goldman SachsGSCOMMENTJan 16, 2015Stock price when the opinion was issued
As of Jul 21, 2026. Market Open.
Different businesses. LLY is a big play in GLP-1 drugs. How will pills effect the injections business? LLY has done a good job of navigating these new pills. GS enjoys increased stock market and IPO businesses. He prefers LLY, which is tied to a secular growth trend, but GS' good times in capturing revenue in this cycle will end.
Mergers are increasing, and banks like GS makes advisory fees from them. Also, the banks have been rallying since oil slumped, and will benefit further from rising interest rates, which appears will happen later this year. Plus, hyperscalers may need to keep borrowing money to keep competing with each other.
If looking to invest in this bank, you really have to ask yourself “what is the exposure that I want to achieve?”. Some US banks have exposure to the retail consumer, and this one would not fit. Very heavily dependent on merger and acquisition and wealth management. He prefers to play the consumer in the US. You could do this through Bank of America (BAC-N) or Wells Fargo (WFC-N). He prefers to play this through regional banks such as National PA Bancshares (NPBC-Q), as not all regions in the US are recovering at the same pace. (See Top Picks.)